PDS Biotechnology (PDSB) Balance Sheet: Assets & Liabilities

PDS Biotechnology (PDSB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), PDS Biotechnology reported total assets of $30.49M and total liabilities of $21.24M. Shareholders' equity was $9.25M, down 51.3% from $19.00M a year earlier. Total debt stood at $16.86M against $26.71M in cash and short-term investments, a net cash position of $9.85M. That puts debt-to-equity at 1.82, compared with 1.15 a year earlier.

PDS Biotechnology Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for PDS Biotechnology Corporation (PDSB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	26.71	41.69	56.56	73.82	65.24	65.24	28.84	12.16	34.65	88.07
Cash & Short-Term Investments	26.71	41.69	56.56	73.82	65.24	65.24	28.84	12.16	34.65	88.07
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00
Other Current Assets	1.54	3.36	2.49	2.66	1.60	1.60	1.50	2.31	1.01	0.05
Total Current Assets	28.25	45.05	59.06	76.48	66.84	66.84	30.34	14.47	35.65	89.05
Non-Current Assets
Property, Plant & Equipment (Net)	0.24	0.30	0.34	0.53	0.36	0.36	0.55	0.02	0.43	3.42
Intangible Assets	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.05
Other Non-Current Assets	2.00	0.00	0.00	-	0.00	-	0.00	0.00	0.14	0.10
Total Non-Current Assets	2.24	0.30	0.34	0.53	0.36	0.36	0.55	0.02	0.57	3.57
Total Assets	30.49	45.36	59.39	77.01	67.20	67.20	30.89	14.49	36.22	92.62
Current Liabilities
Accounts Payable	3.57	1.68	6.98	1.22	1.31	1.31	1.42	1.20	0.40	4.37
Short-Term Debt	5.13	12.56	4.17	0.29	0.26	-	0.12	0.00	0.00	3.08
Accrued Liabilities	0.47	2.84	1.14	6.48	-	0.73	1.74	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00	0.03
Other Current Liabilities	0.74	2.84	2.42	8.31	2.19	-	1.74	1.60	5.98	5.42
Total Current Liabilities	9.48	17.09	13.63	9.82	3.76	3.76	3.27	2.79	6.38	12.87
Non-Current Liabilities
Long-Term Debt	11.73	9.27	19.51	23.02	0.23	0.23	0.49	0.00	0.03	17.38
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.29	0.00
Total Non-Current Liabilities	11.76	9.27	19.63	23.18	0.23	0.23	0.49	0.00	0.32	17.38
Total Liabilities	21.24	26.35	33.26	33.01	3.99	3.99	3.76	2.79	6.38	30.25
Stockholders' Equity
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.01	0.01
Retained Earnings	-216.61	-182.11	-144.50	-101.56	-60.70	-60.70	-43.79	-28.94	-192.82	-151.95
Accumulated Other Comprehensive Income	0.00	0.00	0.00	-	-	-	0.00	0.00	-0.45	-0.31
Additional Paid-in Capital	225.84	201.10	170.62	145.55	123.90	123.90	70.91	40.63	222.64	214.31
Shares Outstanding	54.88	37.99	33.09	30.17	-	28.45	-	-	-	-
Total Stockholders' Equity	9.25	19.00	26.13	44.00	63.21	63.21	27.13	11.70	29.84	62.37
Total Liabilities & Equity	30.49	45.36	59.39	77.01	67.20	67.20	30.89	14.49	36.22	92.62

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About PDS Biotechnology Balance Sheet

How much debt does PDS Biotechnology have?

PDS Biotechnology had total debt of $16.86M as of Dec 31, 2025, against $26.71M in cash and short-term investments. Its debt-to-equity ratio was 1.82. Total debt was $21.83M a year earlier.

What are PDS Biotechnology's total assets?

PDS Biotechnology reported total assets of $30.49M as of Dec 31, 2025, down 32.8% from $45.36M a year earlier. Total liabilities were $21.24M.

What is PDS Biotechnology's shareholders' equity?

PDS Biotechnology's shareholders' equity was $9.25M as of Dec 31, 2025, or about $0.17 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition